Загрузка...
Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia
Adult acute lymphoblastic leukemia (ALL) has a poor overall survival compared with pediatric ALL where cure rates are observed in more than 90% of patients. The recent development of novel monoclonal antibodies targeting CD20, CD19, and CD22 has changed the long-term outcome of this disease, both in...
Сохранить в:
| Опубликовано в: : | Ther Adv Hematol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535741/ https://ncbi.nlm.nih.gov/pubmed/31205644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719849496 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|